logo

Proteostasis Therapeutics, Inc. (PTI)



Trade PTI now with
  Date
  Headline
6/1/2020 7:08:26 AM Proteostasis Therapeutics Announces In Vitro Data For PTI-129 As Potential Treatment Candidate For COVID-19
5/15/2020 4:39:53 PM Proteostasis Therapeutics Q1 Loss/share $0.19 Vs. Loss $0.28 Year Ago
4/13/2020 8:14:09 AM Proteostasis Therapeutics Receives Scientific Advice From The Dutch MEB On CHOICES Program
3/10/2020 4:41:00 PM Proteostasis Therapeutics Q4 Loss/share $0.23 Vs. Loss $0.36 Year Ago
12/17/2019 7:33:24 AM Proteostasis: Positive Phase 2 Topline Results From Proprietary CFTR Modulator Combinations In F508del Homozygous CF
12/11/2019 7:16:26 AM Proteostasis To Initiate Personalized Medicine-Based Clinical Trial In European CF Patients With Genotypes Ineligible
12/2/2019 7:06:22 AM Proteostasis Therapeutics Regains Compliance With Nasdaq Listing Standards
6/4/2019 7:08:54 AM Proteostasis Therapeutics Receives Orphan Drug Designation In EU For PTI-428 For Cystic Fibrosis
6/3/2019 7:08:21 AM Proteostasis Therapeutics Announces Presentations And Hosts Educational Symposium
3/25/2019 7:08:44 AM Proteostasis Therapeutics Announces Results From Phase 1 Clinical Studies Of Its Proprietary CFTR Modulators
2/6/2019 8:07:15 AM MJ Holdings Adds Emmanuel Dulac And Kim Cobleigh Drapkin To Board
12/17/2018 7:02:45 AM Proteostasis Therapeutics Unveils Global License Deal With Genentech